Barrie, Ontario-based SCL Group is a venture investor with activity in South Korea and the United States, focused on later-stage healthcare and life sciences opportunities. The firm has acted as a co-lead investor in Series B financing, with sector relevance across biotechnology, HealthTech, life sciences and oncology. It is most relevant for growth-stage healthcare companies seeking venture capital.